Results 161 to 170 of about 494,691 (265)

Public acceptance and expectations for Lecanemab: Insights from a Smallest Worthwhile Difference study

open access: yesPsychiatry and Clinical Neurosciences, Volume 80, Issue 9, Page 740-747, September 2026.
Aim To determine the smallest worthwhile difference (SWD) for lecanemab, a disease‐modifying drug for Alzheimer's disease (AD), among the general Japanese population using a benefit‐harm trade‐off method. Methods We conducted an online survey with 658 participants to evaluate their preferences for the treatment effect of lecanemab, given its associated
Aran Tajika   +5 more
wiley   +1 more source

Early stage non–small cell lung cancer: Toward a risk‐adaptive paradigm in the era of biologic precision

open access: yesCA: A Cancer Journal for Clinicians, Volume 76, Issue 5, September/October 2026.
Abstract The clinical landscape of early stage non–small cell lung cancer is at transformative crossroads. Driven by the widespread adoption of low‐dose computed tomography screening, the frequent detection of ground‐glass opacities, and a rising incidence among never‐smokers, the diagnostic center of gravity has shifted toward earlier, potentially ...
Chaoqi Zhang   +23 more
wiley   +1 more source

Detection and identification of vacancy defects in antimony selenide. [PDF]

open access: yesNat Commun
Keeble DJ   +8 more
europepmc   +1 more source

First ex-vivo positronium imaging of tissues with modular J-PET scanner using <sup>44</sup>Sc radionuclide. [PDF]

open access: yesZ Med Phys
Kubat K   +43 more
europepmc   +1 more source

Synergistic anion-cation descriptor for bidirectional electrocatalyst in Li-CO<sub>2</sub> battery. [PDF]

open access: yesSci Adv
Zhai X   +13 more
europepmc   +1 more source

From Disease Silos to Integrated Cardiometabolic Care: Diabetes, Vascular Disease, and Heart Failure

open access: yes
Journal of Diabetes, Volume 18, Issue 9, September 2026.
Zachary T. Bloomgarden   +1 more
wiley   +1 more source

Home - About - Disclaimer - Privacy